Location: San Francisco, CA
CIK: 0001056807 · Show all filings
Period: Q2 2017 (← Previous) (Next →)
Filing Date: Aug 14, 2017
Total Value: $644M (99.2% shares, 0.8% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | BLUEPRINT MEDICINES CORP | 1,591,646 | $80.65M | 12.5% | — | — | COM | 09627Y109 |
| — | CHEMOCENTRYX INC | 8,248,416 | $77.2M | 12.0% | — | — | COM | 16383L106 |
| — | ARRAY BIOPHARMA INC | 6,059,625 | $50.72M | 7.9% | — | — | COM | 04269X105 |
| ANAB | ANAPTYSBIO INC | 1,659,200 | $39.7M | 6.2% | — | — | COM | 032724106 |
| — | LOXO ONCOLOGY INC | 463,386 | $37.16M | 5.8% | — | — | COM | 548862101 |
| — | GLYCOMIMETICS INC | 2,970,182 | $33.15M | 5.1% | — | — | COM | 38000Q102 |
| CTMX | CYTOMX THERAPEUTICS INC | 2,026,998 | $31.42M | 4.9% | — | — | COM | 23284F105 |
| — | CTI BIOPHARMA CORP | 8,596,357 | $28.45M | 4.4% | — | — | COM NEW | 12648L601 |
| — | FORWARD PHARMA A/S | 1,387,853 | $28.21M | 4.4% | — | — | SPONSORED ADR | 34986J105 |
| — | CONCERT PHARMACEUTICALS INC | 1,856,895 | $25.9M | 4.0% | — | — | COM | 206022105 |
| CYTK | CYTOKINETICS INC | 1,990,321 | $24.08M | 3.7% | — | — | COM NEW | 23282W605 |
| — | PIERIS PHARMACEUTICALS INC | 3,491,933 | $17.67M | 2.7% | — | — | COM | 720795103 |
| — | ACHILLION PHARMACEUTICALS INC | 3,490,077 | $16.02M | 2.5% | — | — | COM | 00448Q201 |
| — | TOCAGEN INC | 1,279,078 | $15.39M | 2.4% | — | — | COM | 888846102 |
| — | BIOLINERX LTD | 17,500,000 | $14.88M | 2.3% | — | — | SPONSORED ADR | 09071M106 |
| — | ONCOMED PHARMACEUTICALS INC | 4,400,289 | $14.65M | 2.3% | — | — | COM | 68234X102 |
| INFIQ | INFINITY PHARMACEUTICALS INC | 7,866,108 | $12.35M | 1.9% | — | — | COM | 45665G303 |
| — | CASCADIAN THERAPEUTICS INC | 3,133,224 | $11.64M | 1.8% | — | — | COM NEW | 14740B606 |
| XENE | XENON PHARMACEUTICALS INC | 3,518,830 | $11.08M | 1.7% | — | — | COM | 98420N105 |
| XOMA | XOMA CORP DEL | 1,502,800 | $10.51M | 1.6% | — | — | COM NEW | 98419J206 |
| — | ARQULE INC | 7,400,128 | $9.176M | 1.4% | — | — | COM | 04269E107 |
| — | SPRING BK PHARMACEUTICALS INC | 615,384 | $8.332M | 1.3% | — | — | COM | 849431101 |
| — | IGNYTA INC | 700,000 | $7.245M | 1.1% | — | — | COM | 451731103 |
| — | NIVALIS THERAPEUTICS INC | 2,644,806 | $6.374M | 1.0% | — | — | COM | 65481J109 |
| — | GTX INC DEL | 1,108,433 | $5.864M | 0.9% | — | — | COM NEW | 40052B207 |
| — | OREXIGEN THERAPEUTICS INC | 10,000,000 | $5.025M | 0.8% | — | — | NOTE 2.750% | 686164AB0 |
| — | SUNESIS PHARMACEUTICALS INC | 1,770,692 | $4.781M | 0.7% | — | — | COM PAR | 867328700 |
| — | ADURO BIOTECH INC | 300,000 | $3.42M | 0.5% | — | — | COM | 00739L101 |
| CRVS | CORVUS PHARMACEUTICALS INC | 274,196 | $3.318M | 0.5% | — | — | COM | 221015100 |
| — | REGULUS THERAPEUTICS INC | 3,278,900 | $3.232M | 0.5% | — | — | COM | 75915K101 |
| — | OREXIGEN THERAPEUTICS INC | 734,976 | $2.131M | 0.3% | — | — | COM NEW | 686164302 |
| ANTH | ANTHERA PHARMACEUTICALS INC | 1,006,507 | $1.631M | 0.3% | — | — | COM | 03674U300 |
| — | PAIN THERAPEUTICS INC | 325,508 | $1.341M | 0.2% | — | — | COM NEW | 69562K506 |
| FATE | FATE THERAPEUTICS INC | 391,386 | $1.268M | 0.2% | — | — | COM | 31189P102 |